This content is not intended to be a substitute for professional medical advice, diagnosis or treatment
GLP-1Ra at doses intended for T2D management Studies have examined the risk of fracture in both obese and non-obese individuals taking GLP-1Ra at doses intended for T2D (such as liraglutide 1.2 mg daily versus 3.0 mg daily for obesity) [75,76,77]
doi: 10.3168/jds.2022-22656
Unlike semaglutide (a large peptide requiring specialized absorption technology), orforglipron is a small molecule that absorbs more reliably through the GI tract, can be taken with food, and is cheaper to manufacture
[DOI] [PubMed] [Google Scholar] 23.Olszewska M, Banka A, Gorska R, Warszawik O
Stay head of the aging process